Results 31 to 40 of about 8,775 (171)

Micropulse diode laser cyclophotocoagulation in refractory pediatric glaucoma: 2-year follow-up after treatment with a high energy level

open access: yesDelta Journal of Ophthalmology, 2021
Aim The aim of this study was to investigate the safety and long-term efficiency of high-energy-level micropulse diode laser application in the treatment of refractory pediatric glaucoma patients.
Hazem Helmy
doaj   +1 more source

Long-term follow-up of zonulo-hyaloido-vitrectomy for pseudophakic malignant glaucoma

open access: yesIndian Journal of Ophthalmology, 2014
Purpose: To report long-term follow-up of zonulo-hyaloido-vitrectomy (ZHV) via anterior approach for pseudophakic malignant glaucoma refractory to medical treatment. Design: Noncomparative case-series. Materials and Methods: Medical records of 9 patients
Indira M Madgula, Nitin Anand
doaj   +1 more source

Risk factors affecting progression and course of primary open-angle glaucoma in patients with different disease stages (multicenter study) [PDF]

open access: yesКлиническая офтальмология, 2022
N.E. Fomin1,2, P.Ch. Zavadskiy3, A.V. Kuroedov1,2, A.V. Seleznev4, Z.M. Nagornova4, D.A. Baryshnikova5, R.V. Avdeev6, A.M. Getmanova7, I.A. Glushnev8, A.A. Gusarevich9, D.A. Dorofeev10, S.V. Kosmynina11, O.S. Myakonkaya12, N.A.
N.E. Fomin   +16 more
doaj  

Outcomes of the Paul Glaucoma Implant in Refractory Secondary Glaucoma

open access: yesClinical Ophthalmology
To evaluate the efficacy and safety of the Paul Glaucoma Implant (PGI) surgery in patients with secondary glaucomas.Retrospective chart review of adult patients with medically recalcitrant secondary glaucoma who underwent PGI implantation at a single tertiary center between August 2022 and June 2023.
Mohamed Khodeiry   +4 more
openaire   +5 more sources

Clinical Outcomes of FP-7/8 Ahmed Glaucoma Valves in the Management of Refractory Glaucoma in the Mainland Chinese Population. [PDF]

open access: yesPLoS ONE, 2015
To evaluate the efficacy and safety of the Ahmed glaucoma valve (AGV) and the risk factors associated with AGV implantation failure in a population of Chinese patients with refractory glaucoma.In total, 79 eyes with refractory glaucoma from 79 patients ...
Yingting Zhu   +6 more
doaj   +1 more source

The Ahmed Glaucoma Valve in Refractory Glaucoma: experiences in Indian Eyes [PDF]

open access: yesEye, 2004
To evaluate the efficacy of the Ahmed Glaucoma Valve implant in refractory glaucomas in Indian eyes.A retrospective review was conducted on the charts of 122 eyes of 122 patients with refractory glaucoma treated with Ahmed Glaucoma Valve implant placement at Guru Nanak Eye Centre, New Delhi between January 1996 and December 1999.
J C, Das   +3 more
openaire   +2 more sources

Post-keratoplasty glaucoma—Tackling tube exposure

open access: yesIndian Journal of Ophthalmology. Case Reports, 2023
Glaucoma drainage implants (GDI) are sometimes used in the treatment of refractory glaucoma associated with keratoplasty. An important complication of GDI is the exposure of the drainage tube.
Radhika Natarajan, Madhuvanthi Mohan
doaj   +1 more source

The regulation of stem cell fate and its application in neural regeneration

open access: yesInterdisciplinary Medicine, EarlyView.
Regulating stem cell fate is crucial for neural regeneration. This review summarizes key physical, biological, and chemical strategies and their applications in repairing nerve injuries, providing new insights for regenerative medicine. Abstract Regulating the fate of stem cells (SCs) is a key technical problem in the field of regenerative medicine and
Yuexin He   +3 more
wiley   +1 more source

Drainage surgery for primary open-angle glaucoma: past, present, future

open access: yesОфтальмохирургия, 2021
Relevance. Despite many techniques for reducing intraocular pressure, surgical treatment of glaucoma has limited effectiveness. First, due to excessive scarring of new intraocular fluid outflow pathways and second, antifibrotics medicaments are unable to
A. S. Basinsky   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy